Efrat Shema's Lab

Decoding the Cancer Epigenome

Selected Publications

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

Isshiki Y., Chen X., Teater M. et al. (2024) Cancer Cell. 43, 1, p. 49-68.e9

ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response

Lim L. Q. J., Adler L., Hajaj E. et al. (2024) Nature metabolism. 6, 7, p. 1294-1309

Cancer Hallmarks: Piecing the Puzzle Together

Alcolea M. P., Alonso-Curbelo D., Ambrogio C. et al. (2024) Cancer Discovery. 14, 4, p. 674-682
All Publications